drugset / Trial / NCT02544776

Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

NCT02544776

Completed 60 enrolled Ahmed Fathy Ali Mohamed Ghanem
Non-randomizedSingle-groupSingle-blindTreatment

Summary

On the basis of the current study, amlodipine seems to be a promising drug on improving uterine, ovarian blood flow, size of pre-ovulatory follicle, midluteal progesterone level and pregnancy outcome in patients with pco.

Timeline

Start
2015-01
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg Oral
Subject Clomiphene Other / unclassified 50 mg Oral

Indications